Taiwan
· Delayed Price · Currency is TWD Sinew Pharma Statistics
Total Valuation
Sinew Pharma has a market cap or net worth of TWD 4.77 billion. The enterprise value is 3.57 billion.
| Market Cap | 4.77B |
| Enterprise Value | 3.57B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sinew Pharma has 71.33 million shares outstanding. The number of shares has increased by 1.87% in one year.
| Shares Outstanding | 71.33M |
| Shares Change (YoY) | +1.87% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 5.06% |
| Owned by Institutions (%) | 0.03% |
| Float | 58.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.98 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -27.84 |
Financial Position
The company has a current ratio of 44.44, with a Debt / Equity ratio of 0.48.
| Current Ratio | 44.44 |
| Quick Ratio | 44.41 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -317.54 |
Financial Efficiency
Return on equity (ROE) is -13.35% and return on invested capital (ROIC) is -9.14%.
| Return on Equity (ROE) | -13.35% |
| Return on Assets (ROA) | -9.00% |
| Return on Capital (ROIC) | -9.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.50M |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.47% |
| 50-Day Moving Average | 70.04 |
| 200-Day Moving Average | 66.79 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 43,726 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -196.87M |
| Pretax Income | -178.48M |
| Net Income | -178.48M |
| EBITDA | -173.07M |
| EBIT | -196.87M |
| Earnings Per Share (EPS) | -2.52 |
Balance Sheet
The company has 1.21 billion in cash and 6.10 million in debt, giving a net cash position of 1.21 billion or 16.91 per share.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 6.10M |
| Net Cash | 1.21B |
| Net Cash Per Share | 16.91 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 17.72 |
| Working Capital | 1.21B |
Cash Flow
In the last 12 months, operating cash flow was -123.20 million and capital expenditures -4.88 million, giving a free cash flow of -128.08 million.
| Operating Cash Flow | -123.20M |
| Capital Expenditures | -4.88M |
| Free Cash Flow | -128.08M |
| FCF Per Share | -1.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sinew Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.87% |
| Shareholder Yield | -1.87% |
| Earnings Yield | -3.76% |
| FCF Yield | -2.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |